| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 395,837 | 405,263 | 390,827 | 1,450,985 | | Cost of Revenue | 358,829 | 373,005 | 351,929 | 1,407,829 | | | Gross Profit | 37,008 | 32,258 | 38,898 | 43,156 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,382 | 14,893 | 15,535 | 14,592 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,626 | 17,365 | 23,363 | 28,564 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 809 | | Earnings Before Interest And Taxes | 10,151 | 17,365 | 23,363 | 29,373 | | Interest Expense | (8,503) | 4,180 | 4,323 | 6,280 | | Income Before Tax | 18,654 | 13,185 | 19,040 | 23,093 | | Income Tax Expense | 7,158 | 4,977 | 6,969 | 8,353 | | Minority Interest | (997) | 419 |
-
|
-
| | | | Net Income From Continuing Ops | 11,077 | 8,627 | 12,071 | 14,740 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (60) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,655 | 8,627 | 12,071 | 14,680 | | Preferred Stock And Other Adjustments | (1,670) | (1,233) | (1,733) | (2,114) | | | Net Income Applicable To Common Shares | $9,985 | $7,394 | $10,338 | $12,566 |
|
0.02% Nasdaq 0.00%
Income Statement
